ArticleNeuro-oncology2022

Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.

Zhihui Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.